Skip to main content

Publications

featured publications

  • Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3.

    Research and practice in thrombosis and haemostasis

    Authors: Michael U Callaghan, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse-Jarres, Víctor Jiménez-Yuste, Midori Shima, Peter Trask, Christine L Kempton, Craig M Kessler, Gallia G Levy, Flora Peyvandi

  • Assay for ADAMTS-13 Activity with Flow Cytometric Readout.

    ACS omega

    Authors: Jens Müller, Nasim Shahidi Hamedani, Hannah L McRae, Heiko Rühl, Johannes Oldenburg, Bernd Pötzsch

  • Membrane Properties of Human Induced Pluripotent Stem Cell-Derived Cultured Red Blood Cells.

    Cells

    Authors: Claudia Bernecker, Eva Maria Matzhold, Dagmar Kolb, Afrim Avdili, Lisa Rohrhofer, Annika Lampl, Martin Trötzmüller, Heike Singer, Johannes Oldenburg, Peter Schlenke, Isabel Dorn

  • Optimization and evaluation of a two-stage chromogenic assay procedure for measurement of emicizumab plasma levels.

    PloS one

    Authors: Nasim Shahidi Hamedani, Johannes Oldenburg, Bernd Pötzsch, Jens Müller

  • Recent advances in therapeutic options for rare hemostatic disorders: selected poster extracts of recent research in hemophilia A, congenital hemophilia with inhibitors, von Willebrand disease, and thrombotic thrombocytopenic purpura presented at the …

    Expert review of hematology

    Authors: Nisha Jain, Johannes Oldenburg, Margareth C Ozelo, Shawn X Sun, Leilei Tang, Spiros Tzivelekis

  • Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors.

    Research and practice in thrombosis and haemostasis

    Authors: Claude Négrier, Johannes Oldenburg, Gili Kenet, Shannon L Meeks, Jean-Claude Bordet, Jens Müller, Sandra Le Quellec, Peter L Turecek, Nikola Tripkovic, Yesim Dargaud

  • Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors.

    Blood advances

    Authors: Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Hermann Eichler, Victor Jiménez-Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P Wheeler, Guy Young, Silva Zupančić-Šalek, Johannes Oldenburg, Pratima Chowdary

  • Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study.

    TH open : companion journal to thrombosis and haemostasis

    Authors: Carmen Escuriola Ettingshausen, Vladimír Vdovin, Nadezhda Zozulya, Pavel Svirin, Tatiana Andreeva, Majda Benedik-Dolničar, Victor Jiménez-Yuste, Lidija Kitanovski, Silva Zupancic-Šalek, Anna Pavlova, Angelika Bátorová, Cesar Montaño Mejía, Gulnara Abdilova, Sigurd Knaub, Martina Jansen, Shannely Lowndes, Larisa Belyanskaya, Olaf Walter, Johannes Oldenburg

  • Safety of intramuscular COVID-19 vaccination in patients with haemophilia.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Andreas Tiede, Hendrik Leise, Silvia Horneff, Johannes Oldenburg, Susan Halimeh, Christine Heller, Christoph Königs, Katharina Holstein, Christian Pfrepper

  • Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism.

    Life (Basel, Switzerland)

    Authors: Sara Reda, Eva Rudde, Jens Müller, Nasim Shahidi Hamedani, Johannes Oldenburg, Bernd Pötzsch, Heiko Rühl